Cargando…

Cognitive remission: a novel objective for the treatment of major depression?

BACKGROUND: Cognitive dysfunction in major depressive disorder (MDD) encompasses several domains, including but not limited to executive function, verbal memory, and attention. Furthermore, cognitive dysfunction is a frequent residual manifestation in depression and may persist during the remitted p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bortolato, Beatrice, Miskowiak, Kamilla W., Köhler, Cristiano A., Maes, Michael, Fernandes, Brisa S., Berk, Michael, Carvalho, André F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Opinion
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4724131/ https://www.ncbi.nlm.nih.gov/pubmed/26801406 http://dx.doi.org/10.1186/s12916-016-0560-3

Ejemplares similares

Cognitive dysfunction in bipolar disorder and schizophrenia: a systematic review of meta-analyses
por: Bortolato, Beatrice, et al.
Publicado: (2015)

The new field of ‘precision psychiatry’
por: Fernandes, Brisa S., et al.
Publicado: (2017)

The renin–angiotensin system: a possible new target for depression
por: Vian, João, et al.
Publicado: (2017)

The Involvement of TNF-α in Cognitive Dysfunction Associated with Major Depressive Disorder: An Opportunity for Domain Specific Treatments
por: Bortolato, Beatrice, et al.
Publicado: (2015)

Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses
por: Morris, Gerwyn, et al.
Publicado: (2015)

Precision Nomothetic Medicine in Depression Research: A New Depression Model, and New Endophenotype Classes and Pathway Phenotypes, and A Digital Self
por: Maes, Michael
Publicado: (2022)

So depression is an inflammatory disease, but where does the inflammation come from?
por: Berk, Michael, et al.
Publicado: (2013)

An ethnographic study of the effects of cognitive symptoms in patients with major depressive disorder: the IMPACT study
por: Ebert, Bjarke, et al.
Publicado: (2017)

Role of trazodone in treatment of major depressive disorder: an update
por: Fagiolini, Andrea, et al.
Publicado: (2023)

Mechanisms Underlying Neurocognitive Dysfunctions in Recurrent Major Depression
por: Gałecki, Piotr, et al.
Publicado: (2015)

The role of cognitive dysfunction in the symptoms and remission from depression
por: Gonda, Xenia, et al.
Publicado: (2015)

Aspirin: a review of its neurobiological properties and therapeutic potential for mental illness
por: Berk, Michael, et al.
Publicado: (2013)

ABCB1 polymorphism predicts escitalopram dose needed for remission in major depression
por: Singh, A B, et al.
Publicado: (2012)

Staging in bipolar disorder: one step closer to precision psychiatry
por: Fernandes, Brisa S., et al.
Publicado: (2017)

The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders
por: Morris, Gerwyn, et al.
Publicado: (2015)

Evidence-based umbrella review of 162 peripheral biomarkers for major mental disorders
por: Carvalho, André F., et al.
Publicado: (2020)

Manipulating the sleep-wake cycle and circadian rhythms to improve clinical management of major depression
por: Hickie, Ian B, et al.
Publicado: (2013)

Screening for cognitive impairment among patients with work-related stress complaints in Denmark: validation and evaluation of objective and self-report tools
por: Jensen, Johan Høy, et al.
Publicado: (2022)

Mirroring everyday clinical practice in clinical trial design: a new concept to improve the external validity of randomized double-blind placebo-controlled trials in the pharmacological treatment of major depression
por: Severus, Emanuel, et al.
Publicado: (2012)

quality of remission in the major depressive disorder
por: Chebli, H., et al.
Publicado: (2023)

Duloxetine in the treatment of major depressive disorder
por: Goldstein, David J
Publicado: (2007)

Desvenlafaxine in the treatment of major depressive disorder
por: Lourenco, Maria Teresa C, et al.
Publicado: (2009)

Does Cognitive Dysfunction in Bipolar Disorder Qualify as a Diagnostic Intermediate Phenotype?—A Perspective Paper
por: Kessing, Lars Vedel, et al.
Publicado: (2018)

Moving towards a population health approach to the primary prevention of common mental disorders
por: Jacka, Felice N, et al.
Publicado: (2012)

Myalgic encephalomyelitis/chronic fatigue syndrome and encephalomyelitis disseminata/multiple sclerosis show remarkable levels of similarity in phenomenology and neuroimmune characteristics
por: Morris, Gerwyn, et al.
Publicado: (2013)

Transdermal selegiline for the treatment of major depressive disorder
por: Lee, Kelly C, et al.
Publicado: (2007)

A New Characterization of Mental Health Disorders Using Digital Behavioral Data: Evidence from Major Depressive Disorder
por: Taliaz, Dekel, et al.
Publicado: (2021)

Patient-evaluated cognitive function measured with smartphones and the association with objective cognitive function, perceived stress, quality of life and function capacity in patients with bipolar disorder
por: Faurholt-Jepsen, Maria, et al.
Publicado: (2020)

Augmentation treatment in major depressive disorder: focus on aripiprazole
por: Nelson, J Craig, et al.
Publicado: (2008)

Neurocognitive processing of infant stimuli in mothers and non-mothers: psychophysiological, cognitive and neuroimaging evidence
por: Bjertrup, Anne, et al.
Publicado: (2021)

Immuno-psychiatry: an agenda for clinical practice and innovative research
por: Leboyer, Marion, et al.
Publicado: (2016)

Discrepancy between objective and subjective cognition in adults with major depressive disorder
por: Srisurapanont, Manit, et al.
Publicado: (2017)

Neural and Behavioral Predictors of Treatment Efficacy on Mood Symptoms and Cognition in Mood Disorders: A Systematic Review
por: Seeberg, Ida, et al.
Publicado: (2018)

Promoting and Optimizing the Use of 3D-Printed Objects in Spontaneous Recognition Memory Tasks in Rodents: A Method for Improving Rigor and Reproducibility
por: Inayat, Mehreen, et al.
Publicado: (2021)

Defining Auditory-Visual Objects: Behavioral Tests and Physiological Mechanisms
por: Bizley, Jennifer K., et al.
Publicado: (2016)

Effects of Short-Term Cognitive Remediation on Cognitive Dysfunction in Partially or Fully Remitted Individuals with Bipolar Disorder: Results of a Randomised Controlled Trial
por: Demant, Kirsa M., et al.
Publicado: (2015)

Concordance between actual and pharmacogenetic predicted desvenlafaxine dose needed to achieve remission in major depressive disorder: a 10-week open-label study
por: Bousman, Chad A., et al.
Publicado: (2017)

GSK3β: a plausible mechanism of cognitive and hippocampal changes induced by erythropoietin treatment in mood disorders?
por: Inkster, Becky, et al.
Publicado: (2018)

New developments in the management of major depressive disorder and generalized anxiety disorder: role of quetiapine
por: Baune, Bernhard T
Publicado: (2008)

Treatment strategies to improve and sustain remission in major depressive disorder
por: Madhukar H., Trivedi, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_on2kqcd8hui8q5peh3idsjt7mu